TY - JOUR
TI - Reply to the letter to the editor 'Re-aligning the ASCO and ESMO clinical benefit frameworks or modern cancer therapies'
AU - Cherny, N.I.
AU - Dafni, U.
AU - Bogaerts, J.
AU - Latino, N.J.
AU - Pentheroudakis, G.
AU - Douillard, J.-Y.
AU - Tabernero, J.
AU - Zielinski, C.
AU - Piccart, M.J.
AU - de Vries, E.G.E.
JO - Annals of Oncology
PY - 2018
VL - 29
TODO - 3
SP - 774-775
PB - Oxford University Press
SN - 0923-7534, 1569-8041
TODO - 10.1093/annonc/mdx747
TODO - biomedical technology assessment;  cancer therapy;  clinical effectiveness;  conceptual framework;  health care policy;  health care system;  human;  Letter;  palliative therapy;  patient decision making;  practice guideline;  priority journal;  reimbursement;  neoplasm;  oncology, Humans;  Medical Oncology;  Neoplasms
TODO - null
ER -